These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1314334

  • 1. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S, Hohlfeld R.
    Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa, Kir'iakov VA, Sapfirova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Feb; 90(2):119-26. PubMed ID: 2160156
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL, Dau PC, Khatri BO, Petajan J, Birnbaum G, McQuillen MP, Fosburg MT, Feldstein M, Orav J.
    Prog Clin Biol Res; 1990 Feb; 337():283. PubMed ID: 2162062
    [No Abstract] [Full Text] [Related]

  • 4. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL, Fosburg M, Kevy S, Weiner HL.
    Prog Clin Biol Res; 1982 Feb; 106():239-54. PubMed ID: 6184727
    [Abstract] [Full Text] [Related]

  • 5. Current medical treatment of multiple sclerosis.
    Alter M.
    Clin Ther; 1983 Feb; 5(5):455-60. PubMed ID: 6193881
    [No Abstract] [Full Text] [Related]

  • 6. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B, Sørensen PS.
    Ugeskr Laeger; 1994 Oct 24; 156(43):6353-8. PubMed ID: 7810008
    [Abstract] [Full Text] [Related]

  • 7. Treatment of multiple sclerosis.
    McFarlin DE.
    N Engl J Med; 1983 Jan 27; 308(4):215-7. PubMed ID: 6294519
    [No Abstract] [Full Text] [Related]

  • 8. Management of multiple sclerosis.
    Poser CM.
    Compr Ther; 1981 Apr 27; 7(4):53-9. PubMed ID: 6263543
    [No Abstract] [Full Text] [Related]

  • 9. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
    Cendrowski W.
    Neurol Neurochir Pol; 1984 Apr 27; 18(3):259-62. PubMed ID: 6390235
    [No Abstract] [Full Text] [Related]

  • 10. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B, Pirskanen R.
    Br Med J (Clin Res Ed); 1985 Sep 28; 291(6499):850-1. PubMed ID: 2996688
    [Abstract] [Full Text] [Related]

  • 11. [Current therapy of multiple sclerosis].
    Vass K, Schmied M.
    Wien Med Wochenschr; 1996 Sep 28; 146(19-20):514-9. PubMed ID: 9082651
    [Abstract] [Full Text] [Related]

  • 12. [The dynamics of immunological indicators in the treatment of patients with multiple sclerosis with prednisolone combined with plasmapheresis].
    Neretin VIa, Gannushkina IV, Zhirnova IG, Sapfirova VA, Kir'iakov VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Sep 28; 88(2):17-21. PubMed ID: 3259769
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.
    Dawson DM, Carter JL, Hafler DA, Weiner HL.
    Riv Neurol; 1987 Sep 28; 57(2):88-91. PubMed ID: 3039645
    [Abstract] [Full Text] [Related]

  • 14. [Pathogenesis and treatment of multiple sclerosis. Review and personal results].
    Gérard JM, Hildebrand J, Mavroudakis N, Monseu G, Przedborski S, Seeldrayers P, Wautier J, Zegers de Beyl D.
    Rev Med Brux; 1988 Sep 28; 9(6):334-9. PubMed ID: 2845554
    [No Abstract] [Full Text] [Related]

  • 15. [Lymphocyto-plasmapheresis for relapsing multiple sclerosis].
    Jyoichi T, Kamegai M, Noda Y, Shimojo S, Miyahara T.
    Rinsho Shinkeigaku; 1986 Sep 28; 26(9):907-9. PubMed ID: 3791770
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of multiple sclerosis].
    Kesselring J.
    Schweiz Med Wochenschr; 1984 Sep 01; 114(35):1186-90. PubMed ID: 6091263
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC.
    NITA; 1985 Sep 01; 8(6):503-5. PubMed ID: 2999647
    [No Abstract] [Full Text] [Related]

  • 18. [Multiple sclerosis: an update].
    Duquette P.
    Union Med Can; 1988 Aug 01; 118(3):231-5. PubMed ID: 3051618
    [No Abstract] [Full Text] [Related]

  • 19. [Plasmapheresis in multiple sclerosis].
    Fuchs S, Pogglitsch H, Ladurner G, Lechner H.
    Wien Klin Wochenschr; 1984 Jan 20; 96(2):67-9. PubMed ID: 6710999
    [Abstract] [Full Text] [Related]

  • 20. [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].
    Trouillas P, Neuschwander P, Nighoghossian N, Adeleine P, Tremisi P.
    Rev Neurol (Paris); 1989 Jan 20; 145(5):369-77. PubMed ID: 2662340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.